Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05640895 · ClinicalTrials.gov registry record
Intravitreal Injection Site and Perceived Pain
A clinical trial of Pain, sponsored by The University of Texas Medical Branch, Galveston.
- Completed
- Registry status
- 53
- Enrollment target
- 1
- Study location
NCT05640895: Completed study of Pain, sponsored by The University of Texas Medical Branch, Galveston.
NCT05640895 is a study of Pain that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 53 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05640895, a study of Pain, has completed, sponsored by The University of Texas Medical Branch, Galveston.
- COMPLETED
- Registry status
- 53 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to explore the perception of pain during intravitreal injection related to the distance of the entry site from the limbus.
Primary Outcome
Self-reported perception of pain according to analogue pain scale. The analog pain scale is a scale of numbers from 0 to 10 representing the degree of patient's perceived pain. A score of 0 indicates no perception of pain; a score of 10 indicates a perception of the worst pain possible. The scale is also illustrated with face emojis corresponding to a written description of pain perception from no perception of pain, represented by a green, fully smiling face to perception of the worst pain poss
Conditions Studied
Interventions
- PROCEDURE Intravitreal injection site
Study Locations (1)
Texas
- University of Texas Medical Branch - Galveston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2022-11-14 |
| Est. Completion | 2024-09-09 |
What the finished NCT05640895 record still lists
NCT05640895 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 53 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 1 intervention - of which Intravitreal injection site is the first listed.
NCT05640895 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05640895 about?
NCT05640895 is a clinical study titled "Intravitreal Injection Site and Perceived Pain". The objective of this study is to explore the perception of pain during intravitreal injection related to the distance of the entry site from the limbus.
What is the current status of trial NCT05640895?
This trial is currently completed. The enrollment target is 53 participants. The study started on 2022-11-14. Estimated completion is 2024-09-09.
What conditions does trial NCT05640895 study?
This clinical trial studies the following conditions: Pain.
What interventions are being tested in trial NCT05640895?
The interventions under investigation include: Intravitreal injection site (PROCEDURE).
Who is sponsoring clinical trial NCT05640895?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05640895 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05640895's enrollment target sits among peer trials
53 252nd of 374 higher than 122 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Postoperative Pain After Activation of Irrigant
RECRUITING · NA
-
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
RECRUITING · NA
-
Reliability of Pupil Response to Acute Pain
RECRUITING
-
Pain With Dementia
RECRUITING · NA
-
Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
RECRUITING · Phase 2
-
Defense and Veterans Center for Integrative Pain Management (DVCIPM) Pain Registry Biobank
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI